Breast cancer continues to be the most common malignancy among women worldwide, requiring novel therapeutic approaches. This research investigates an innovative gene delivery strategy employing mesoporous silica nanoparticles (MCM-41) modified with lysine and cysteine (Lys-Cys) for the effective delivery of CRISPR-Cas9 plasmids aimed at the monocyte chemoattractant protein-1 (MCP-1/CCL2) gene. Bioinformatics analysis of the TCGA-BRCA dataset revealed substantial deregulation of CCL2 in breast cancer, underscoring its involvement in tumor growth and inflammation. The MCM/Lys-Cys nanocarrier demonstrated remarkable biocompatibility and effectively encapsulated a plasmid containing GFP, promoting superior cellular uptake in MDA-MB-231 breast cancer cells compared to conventional techniques. Functional experiments demonstrated that CRISPR/Cas9-mediated suppression of CCL2 markedly decreased cell proliferation, migration, and invasion, highlighting the promise of this targeted gene therapy strategy in breast cancer management. The findings indicate that the MCM/Lys-Cys nanosystem presents a viable non-viral approach for precise gene editing, potentially boosting therapeutic efforts against breast cancer by modulating inflammatory pathways.
{"title":"The MCM/Lys-Cys nanodevices for the efficient gene delivery: An approach towards MCP1 gene manipulation using CRISPR technology","authors":"Azadeh Rahimi , Ilnaz Rahimmanesh , Navid Abedpoor , Maryam Boshtam , Elham Bidram , Shaghayegh Haghjooy Javanmard , Hossein Khanahmad , Laleh Rafiee , Ashkan Bigham , Mohammad Rafienia , Saeed Karbasi , Laleh Shariati","doi":"10.1016/j.colsurfb.2025.115377","DOIUrl":"10.1016/j.colsurfb.2025.115377","url":null,"abstract":"<div><div>Breast cancer continues to be the most common malignancy among women worldwide, requiring novel therapeutic approaches. This research investigates an innovative gene delivery strategy employing mesoporous silica nanoparticles (MCM-41) modified with lysine and cysteine (Lys-Cys) for the effective delivery of CRISPR-Cas9 plasmids aimed at the monocyte chemoattractant protein-1 (MCP-1/CCL2) gene. Bioinformatics analysis of the TCGA-BRCA dataset revealed substantial deregulation of CCL2 in breast cancer, underscoring its involvement in tumor growth and inflammation. The MCM/Lys-Cys nanocarrier demonstrated remarkable biocompatibility and effectively encapsulated a plasmid containing GFP, promoting superior cellular uptake in MDA-MB-231 breast cancer cells compared to conventional techniques. Functional experiments demonstrated that CRISPR/Cas9-mediated suppression of CCL2 markedly decreased cell proliferation, migration, and invasion, highlighting the promise of this targeted gene therapy strategy in breast cancer management. The findings indicate that the MCM/Lys-Cys nanosystem presents a viable non-viral approach for precise gene editing, potentially boosting therapeutic efforts against breast cancer by modulating inflammatory pathways.</div></div>","PeriodicalId":279,"journal":{"name":"Colloids and Surfaces B: Biointerfaces","volume":"260 ","pages":"Article 115377"},"PeriodicalIF":5.6,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145825404","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-04-01Epub Date: 2025-12-26DOI: 10.1016/j.colsurfb.2025.115400
Ruqi Wang , Qishu Jin , Zhaoxu Meng , Xiaodong Cao , Yihao Wu , Chen Yang , Jiandong Yuan
Oxidative stress is increasingly recognized as a key pathological driver of skeletal degeneration in diabetes, aging, trauma, and other orthopedic disorders, where excessive reactive oxygen species (ROS) compromise osteoblast and bone marrow mesenchymal stem cell (BMSC) function while promoting osteoclast activity. Natural polyphenols such as baicalein (BA) exhibit potent antioxidant effects but are hindered by poor solubility and limited stability. Here, we report a series of BA-X self-assembled nanoparticles, in which X represents osteogenic metal ions including Mg2 + , Mn2+, Cu2+, Zn2+, and Sr2+. Among these, BA-Mn demonstrated the most robust radical-scavenging activity in DPPH, ABTS, and multiple ROS-targeted assays. BA-Mn exhibited nanoscale dimensions, uniform coordination, and excellent cytocompatibility, significantly reducing intracellular ROS and protecting H2O2-injured BMSCs. Functionally, BA-Mn restored osteogenic differentiation under oxidative stress, enhancing alkaline phosphatase activity, mineral deposition, and osteogenic gene expression. Transcriptomic analysis further revealed concurrent activation of cell cycle, PI3K-Akt, and MAPK signaling pathways, alongside suppression of ferroptosis and ROS-related carcinogenesis. Collectively, these findings establish BA-Mn as a multifunctional nanoplatform that integrates antioxidant defense with osteogenic stimulation, offering a promising therapeutic approach for oxidative stress-related bone disorders.
{"title":"Baicalein-manganese nanoparticles for antioxidant and osteogenic therapy of bone injury","authors":"Ruqi Wang , Qishu Jin , Zhaoxu Meng , Xiaodong Cao , Yihao Wu , Chen Yang , Jiandong Yuan","doi":"10.1016/j.colsurfb.2025.115400","DOIUrl":"10.1016/j.colsurfb.2025.115400","url":null,"abstract":"<div><div>Oxidative stress is increasingly recognized as a key pathological driver of skeletal degeneration in diabetes, aging, trauma, and other orthopedic disorders, where excessive reactive oxygen species (ROS) compromise osteoblast and bone marrow mesenchymal stem cell (BMSC) function while promoting osteoclast activity. Natural polyphenols such as baicalein (BA) exhibit potent antioxidant effects but are hindered by poor solubility and limited stability. Here, we report a series of BA-X self-assembled nanoparticles, in which X represents osteogenic metal ions including Mg<sup>2 +</sup> , Mn<sup>2+</sup>, Cu<sup>2+</sup>, Zn<sup>2+</sup>, and Sr<sup>2+</sup>. Among these, BA-Mn demonstrated the most robust radical-scavenging activity in DPPH, ABTS, and multiple ROS-targeted assays. BA-Mn exhibited nanoscale dimensions, uniform coordination, and excellent cytocompatibility, significantly reducing intracellular ROS and protecting H<sub>2</sub>O<sub>2</sub>-injured BMSCs. Functionally, BA-Mn restored osteogenic differentiation under oxidative stress, enhancing alkaline phosphatase activity, mineral deposition, and osteogenic gene expression. Transcriptomic analysis further revealed concurrent activation of cell cycle, PI3K-Akt, and MAPK signaling pathways, alongside suppression of ferroptosis and ROS-related carcinogenesis. Collectively, these findings establish BA-Mn as a multifunctional nanoplatform that integrates antioxidant defense with osteogenic stimulation, offering a promising therapeutic approach for oxidative stress-related bone disorders.</div></div>","PeriodicalId":279,"journal":{"name":"Colloids and Surfaces B: Biointerfaces","volume":"260 ","pages":"Article 115400"},"PeriodicalIF":5.6,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145877313","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Poly (ethylene terephthalate) (PET) is a widely used synthetic polymer in textiles, but its hydrophobicity limits its applications despite excellent mechanical properties. Enzymatic hydrolysis provides a sustainable and environmentally friendly approach for PET surface modification, but its efficiency is restricted by the polymer’s high crystallinity and limited enzyme accessibility. In this study, a synergistic plasma-enzyme treatment strategy was developed to enhance PET fiber surface hydrophilicity. Molecular dynamics (MD) simulations were employed to identify thermally unstable regions in leaf-branch compost cutinase (LCC), guiding the design of a thermostable variant, KI (T60K/N122I). The engineered KI exhibited a 10 °C improvement in thermal stability and a 1.33-fold increase in hydrolytic efficiency on amorphous PET compared to the native enzyme. PET fibers were subjected to ten sequential plasma–enzyme treatment cycles (90 min, 70 °C each), varying plasma exposure time (90 s and 180 s) and reactive gas type (O₃ or O₂). Surface analyses revealed that pretreatment with O₃ plasma significantly enhanced enzyme activity by promoting higher surface roughness and introducing more oxygen-containing functional groups. The combination of O₃ plasma and KI resulted in 1.5-fold higher water absorption and 1.2-fold higher color strength relative to O₂ plasma–treated samples. Gravimetric measurements confirmed greater mass loss for the O₃–KI system, attributable to enhanced thermal robustness and substrate affinity of the engineered enzyme. Overall, the cyclic plasma–enzyme process demonstrated superior performance compared to conventional modification methods, providing an efficient and sustainable route for functionalizing PET surfaces.
{"title":"Surface modification of PET Fiber: Evaluation of the synergistic effect of a thermostable engineered cutinase with DBD plasma pretreatment","authors":"Afsaneh Zarei , Farzaneh Alihosseini , Farzaneh Jafary","doi":"10.1016/j.colsurfb.2025.115408","DOIUrl":"10.1016/j.colsurfb.2025.115408","url":null,"abstract":"<div><div>Poly (ethylene terephthalate) (PET) is a widely used synthetic polymer in textiles, but its hydrophobicity limits its applications despite excellent mechanical properties. Enzymatic hydrolysis provides a sustainable and environmentally friendly approach for PET surface modification, but its efficiency is restricted by the polymer’s high crystallinity and limited enzyme accessibility. In this study, a synergistic plasma-enzyme treatment strategy was developed to enhance PET fiber surface hydrophilicity. Molecular dynamics (MD) simulations were employed to identify thermally unstable regions in leaf-branch compost cutinase (LCC), guiding the design of a thermostable variant, KI (T60K/N122I). The engineered KI exhibited a 10 °C improvement in thermal stability and a 1.33-fold increase in hydrolytic efficiency on amorphous PET compared to the native enzyme. PET fibers were subjected to ten sequential plasma–enzyme treatment cycles (90 min, 70 °C each), varying plasma exposure time (90 s and 180 s) and reactive gas type (O₃ or O₂). Surface analyses revealed that pretreatment with O₃ plasma significantly enhanced enzyme activity by promoting higher surface roughness and introducing more oxygen-containing functional groups. The combination of O₃ plasma and KI resulted in 1.5-fold higher water absorption and 1.2-fold higher color strength relative to O₂ plasma–treated samples. Gravimetric measurements confirmed greater mass loss for the O₃–KI system, attributable to enhanced thermal robustness and substrate affinity of the engineered enzyme. Overall, the cyclic plasma–enzyme process demonstrated superior performance compared to conventional modification methods, providing an efficient and sustainable route for functionalizing PET surfaces.</div></div>","PeriodicalId":279,"journal":{"name":"Colloids and Surfaces B: Biointerfaces","volume":"260 ","pages":"Article 115408"},"PeriodicalIF":5.6,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145916292","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-04-01Epub Date: 2025-12-25DOI: 10.1016/j.colsurfb.2025.115388
Shuze Wang , Jin Wang , Yue Wang , Xintong Ye , Liyun Zhang , Guangqi Yan , Xue Wang
The use of sutures for stable wound closure in the humid, microbiologically complex oral environment is critical for mucosal healing. However, traditional absorbable sutures often loosen due to oral movements, leading to micro-gaps and accelerated microbial colonization, which disrupts healing. Inspired by spider silk's "expansion-induced supercontraction" in humidity, this study develops tea polyphenols self-contracting sutures to enhance mechanical reinforcement and repair efficiency. This next-generation degradable suture features a spider silk-inspired elastic network: polyvinyl alcohol (PVA) chains provide entropy-driven elastic recovery, while an ion-crosslinked network of sodium alginate and Ca²⁺ serves as a moisture-responsive unit. When dry, the network maintains pre-tension. Upon hydration, water molecules competitively coordinate with alginate and Ca²⁺, reducing crosslink density. This allows the PVA network to actively contract within four hours post-surgery, approximating wound edges, minimizing gaps, and reducing bacterial invasion. This next-generation degradable suture exhibits robust antibacterial activity, with 90.3 % inhibition against E. coli and 95.6 % against S. aureus. It also exerts significant biological regulation: compared to controls, it upregulates anti-inflammatory IL-10 expression by 2.41-fold, enhances oxidative stress scavenging capacity by 1.87-fold, and promotes angiogenesis. In vivo tests on difficult oral wounds show this next-generation degradable suture accelerates healing, reduces scarring, and improves tissue regeneration quality, especially in infected wounds. It holds broad potential for minimally invasive oral and maxillofacial surgeries and infection-prone wound repair.
{"title":"Oral environment targeting sutures for refractory oral wound","authors":"Shuze Wang , Jin Wang , Yue Wang , Xintong Ye , Liyun Zhang , Guangqi Yan , Xue Wang","doi":"10.1016/j.colsurfb.2025.115388","DOIUrl":"10.1016/j.colsurfb.2025.115388","url":null,"abstract":"<div><div>The use of sutures for stable wound closure in the humid, microbiologically complex oral environment is critical for mucosal healing. However, traditional absorbable sutures often loosen due to oral movements, leading to micro-gaps and accelerated microbial colonization, which disrupts healing. Inspired by spider silk's \"expansion-induced supercontraction\" in humidity, this study develops tea polyphenols self-contracting sutures to enhance mechanical reinforcement and repair efficiency. This next-generation degradable suture features a spider silk-inspired elastic network: polyvinyl alcohol (PVA) chains provide entropy-driven elastic recovery, while an ion-crosslinked network of sodium alginate and Ca²⁺ serves as a moisture-responsive unit. When dry, the network maintains pre-tension. Upon hydration, water molecules competitively coordinate with alginate and Ca²⁺, reducing crosslink density. This allows the PVA network to actively contract within four hours post-surgery, approximating wound edges, minimizing gaps, and reducing bacterial invasion. This next-generation degradable suture exhibits robust antibacterial activity, with 90.3 % inhibition against E. coli and 95.6 % against S. aureus. It also exerts significant biological regulation: compared to controls, it upregulates anti-inflammatory IL-10 expression by 2.41-fold, enhances oxidative stress scavenging capacity by 1.87-fold, and promotes angiogenesis. <em>In vivo</em> tests on difficult oral wounds show this next-generation degradable suture accelerates healing, reduces scarring, and improves tissue regeneration quality, especially in infected wounds. It holds broad potential for minimally invasive oral and maxillofacial surgeries and infection-prone wound repair.</div></div>","PeriodicalId":279,"journal":{"name":"Colloids and Surfaces B: Biointerfaces","volume":"260 ","pages":"Article 115388"},"PeriodicalIF":5.6,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145881524","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-04-01Epub Date: 2026-01-06DOI: 10.1016/j.colsurfb.2026.115424
Zheng Zou , Mengjia Chen , Jun Liu , Huan Ma , Guobiao Liang , Jingyuan Li
Traumatic brain injury (TBI) remains one of the most devastating neurological disorders, characterized by complex primary mechanical damage and secondary cascades involving inflammation, oxidative stress, and glial scar formation. Conventional therapies offer limited efficacy due to the blood–brain barrier, the inability to reconstruct tissue defects, and poor spatiotemporal drug control. Hydrogels have emerged as a versatile platform for brain repair owing to their high-water content, biocompatibility, tunable mechanics, and injectability. By tailoring their composition and crosslinking mechanisms, hydrogels can mimic the native brain extracellular matrix, fill irregular cavities, and provide mechanical support that matches neural tissue softness. More importantly, functional hydrogels serve as local delivery vehicles for neuroprotective drugs and growth factors, scaffolds for stem cell transplantation, and active regulators of the post-injury microenvironment. Recent advances include bioactive, conductive, and stimuli-responsive hydrogels capable of modulating immune polarization, enhancing angiogenesis, and promoting neurogenesis. Despite encouraging preclinical results, challenges remain in achieving long-term biocompatibility, precise degradation control, and scalable clinical translation. This review summarizes the current progress, underlying mechanisms, and emerging design strategies of hydrogel-based therapies for TBI, highlighting their potential as next-generation biomaterials for neuroregeneration and functional recovery.
{"title":"Recent advances in hydrogel therapy for traumatic brain injury","authors":"Zheng Zou , Mengjia Chen , Jun Liu , Huan Ma , Guobiao Liang , Jingyuan Li","doi":"10.1016/j.colsurfb.2026.115424","DOIUrl":"10.1016/j.colsurfb.2026.115424","url":null,"abstract":"<div><div>Traumatic brain injury (TBI) remains one of the most devastating neurological disorders, characterized by complex primary mechanical damage and secondary cascades involving inflammation, oxidative stress, and glial scar formation. Conventional therapies offer limited efficacy due to the blood–brain barrier, the inability to reconstruct tissue defects, and poor spatiotemporal drug control. Hydrogels have emerged as a versatile platform for brain repair owing to their high-water content, biocompatibility, tunable mechanics, and injectability. By tailoring their composition and crosslinking mechanisms, hydrogels can mimic the native brain extracellular matrix, fill irregular cavities, and provide mechanical support that matches neural tissue softness. More importantly, functional hydrogels serve as local delivery vehicles for neuroprotective drugs and growth factors, scaffolds for stem cell transplantation, and active regulators of the post-injury microenvironment. Recent advances include bioactive, conductive, and stimuli-responsive hydrogels capable of modulating immune polarization, enhancing angiogenesis, and promoting neurogenesis. Despite encouraging preclinical results, challenges remain in achieving long-term biocompatibility, precise degradation control, and scalable clinical translation. This review summarizes the current progress, underlying mechanisms, and emerging design strategies of hydrogel-based therapies for TBI, highlighting their potential as next-generation biomaterials for neuroregeneration and functional recovery.</div></div>","PeriodicalId":279,"journal":{"name":"Colloids and Surfaces B: Biointerfaces","volume":"260 ","pages":"Article 115424"},"PeriodicalIF":5.6,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145931687","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-04-01Epub Date: 2025-12-23DOI: 10.1016/j.colsurfb.2025.115395
Xueqin Zhang , Peng Chao , Lei Zhang, Yang Zhao, Hui Li, Yipeng Zhou, Xue Song, Shufen Yang, Gulimire Muhetaer, Hong Jiang, Chen Lu
Immunoglobulin A nephropathy (IgAN), the most prevalent primary glomerulonephritis worldwide, is characterized by chronic renal inflammation and progressive decline toward end-stage renal disease. In this study, we integrated single-cell and bulk RNA sequencing approaches to systematically elucidate the role of macrophages in IgAN pathogenesis. Single-cell transcriptomic analysis identified 171 macrophage-associated differentially expressed genes and revealed two distinct molecular subtypes with divergent immune and metabolic signatures. Using machine learning algorithms, we constructed a diagnostic model based on eight macrophage-related markers, including NR4A1, which demonstrated robust predictive accuracy (Area Under the Curve > 0.9) across multiple independent validation cohorts. Functional experiments further established NR4A1 as a protective factor in IgAN. Overexpression of NR4A1 in an IgAN mouse model markedly reduced renal fibrosis, macrophage infiltration, and glomerular injury, whereas NR4A1 knockout exacerbated these pathological features. Mechanistically, the transcription factor ZBTB7A, which is upregulated in IgAN, directly suppresses NR4A1 expression through protein interaction. Rescue experiments demonstrated that NR4A1 overexpression mitigates ZBTB7A-induced renal damage. Collectively, these findings identify the ZBTB7A–NR4A1 regulatory axis as a critical mechanism driving IgAN progression and highlight NR4A1 as a potential diagnostic biomarker and therapeutic target for disease prevention.
{"title":"Integrated analysis of single-cell and bulk RNA-seq data identifies NR4A1-associated macrophages in immunoglobulin A nephropathy","authors":"Xueqin Zhang , Peng Chao , Lei Zhang, Yang Zhao, Hui Li, Yipeng Zhou, Xue Song, Shufen Yang, Gulimire Muhetaer, Hong Jiang, Chen Lu","doi":"10.1016/j.colsurfb.2025.115395","DOIUrl":"10.1016/j.colsurfb.2025.115395","url":null,"abstract":"<div><div>Immunoglobulin A nephropathy (IgAN), the most prevalent primary glomerulonephritis worldwide, is characterized by chronic renal inflammation and progressive decline toward end-stage renal disease. In this study, we integrated single-cell and bulk RNA sequencing approaches to systematically elucidate the role of macrophages in IgAN pathogenesis. Single-cell transcriptomic analysis identified 171 macrophage-associated differentially expressed genes and revealed two distinct molecular subtypes with divergent immune and metabolic signatures. Using machine learning algorithms, we constructed a diagnostic model based on eight macrophage-related markers, including NR4A1, which demonstrated robust predictive accuracy (Area Under the Curve > 0.9) across multiple independent validation cohorts. Functional experiments further established NR4A1 as a protective factor in IgAN. Overexpression of NR4A1 in an IgAN mouse model markedly reduced renal fibrosis, macrophage infiltration, and glomerular injury, whereas NR4A1 knockout exacerbated these pathological features. Mechanistically, the transcription factor ZBTB7A, which is upregulated in IgAN, directly suppresses NR4A1 expression through protein interaction. Rescue experiments demonstrated that NR4A1 overexpression mitigates ZBTB7A-induced renal damage. Collectively, these findings identify the ZBTB7A–NR4A1 regulatory axis as a critical mechanism driving IgAN progression and highlight NR4A1 as a potential diagnostic biomarker and therapeutic target for disease prevention.</div></div>","PeriodicalId":279,"journal":{"name":"Colloids and Surfaces B: Biointerfaces","volume":"260 ","pages":"Article 115395"},"PeriodicalIF":5.6,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145831813","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-04-01Epub Date: 2025-12-19DOI: 10.1016/j.colsurfb.2025.115387
Xin Liu , Zekai Ren , Xin Ding , Han Wu , Yumei Wang , Yang Cao , Hailin Cong , Bing Yu
Wound hemostasis and healing have been important issues faced in wound therapy. Bioactive peptides are widely used in wound therapy due to their good biocompatibility and tunable functionality. Here we prepared Erythrocyte Membrane Chromatography Packing Material (EMCPM) by combining SiO2 stationary-phase microspheres and cell membranes of erythrocytes through diazotized resin, and screened the coagulation peptide KFVLK from mobile phase peptide libraries, which lyophilized in the form of white solid particles with good biosafety, and could rapidly adsorb erythrocytes and platelets to stop wound bleeding. In the liver hemorrhage model, it could stop wound bleeding within 20 s, which reduced blood loss by 50 % compared with the control group. Meanwhile, it has good performance in promoting wound healing, with a healing rate of 88 % on fibroblasts within 24 h. The wound healing model also verified its performance. In conclusion, this screening method is of great significance for the preparation of coagulation peptides and hemostatic treatment of wounds.
{"title":"Screening and application of a coagulation peptide-KFVLK with rapid hemostatic property","authors":"Xin Liu , Zekai Ren , Xin Ding , Han Wu , Yumei Wang , Yang Cao , Hailin Cong , Bing Yu","doi":"10.1016/j.colsurfb.2025.115387","DOIUrl":"10.1016/j.colsurfb.2025.115387","url":null,"abstract":"<div><div>Wound hemostasis and healing have been important issues faced in wound therapy. Bioactive peptides are widely used in wound therapy due to their good biocompatibility and tunable functionality. Here we prepared Erythrocyte Membrane Chromatography Packing Material (EMCPM) by combining SiO<sub>2</sub> stationary-phase microspheres and cell membranes of erythrocytes through diazotized resin, and screened the coagulation peptide KFVLK from mobile phase peptide libraries, which lyophilized in the form of white solid particles with good biosafety, and could rapidly adsorb erythrocytes and platelets to stop wound bleeding. In the liver hemorrhage model, it could stop wound bleeding within 20 s, which reduced blood loss by 50 % compared with the control group. Meanwhile, it has good performance in promoting wound healing, with a healing rate of 88 % on fibroblasts within 24 h. The wound healing model also verified its performance. In conclusion, this screening method is of great significance for the preparation of coagulation peptides and hemostatic treatment of wounds.</div></div>","PeriodicalId":279,"journal":{"name":"Colloids and Surfaces B: Biointerfaces","volume":"260 ","pages":"Article 115387"},"PeriodicalIF":5.6,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145831844","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
The rational design of bio-interfaces that efficiently generate reactive oxygen species (ROS) is crucial for antimicrobial therapies. Here, we present a Z-scheme heterojunction of Bi2S3-Sv/WS2, engineered at the interface through in-situ growth to form covalent Bi-S-W bonds. This specific bonding, coupled with introduced sulfur vacancies, creates an asymmetric electron distribution and a built-in electric field. The synergistic effect establishes a direct and rapid pathway for charge carrier transport, which is conclusively verified by femtosecond transient absorption spectroscopy (fs-TAS) to suppress charge recombination and extend carrier lifetimes. Consequently, the system exhibits a significant enhancement in the generation of reactive oxygen species (ROS) under 660 nm light irradiation. The optimized heterojunction demonstrates broad-spectrum antibacterial efficacy, achieving a 99.63 % inhibition rate against both Staphylococcus aureus and Escherichia coli within 15-minute treatment. Furthermore, the material exhibits excellent biocompatibility. This study discloses the role of interfacial chemical bonding and defect engineering in tailoring charge dynamics at the bio-interface, thereby providing a promising strategy for the rational design of highly efficient photocatalytic agents for biomedical applications, such as wound healing and infection control.
{"title":"Chemical bonding-driven charge transfer in Z-scheme bimetallic sulfides for rapid wound healing","authors":"Jianfang Li , Guoying Jiang , Huijun Meng , Weiduo Zhao , Yuan Tian , Jianlin Xu , Liheng Feng","doi":"10.1016/j.colsurfb.2025.115396","DOIUrl":"10.1016/j.colsurfb.2025.115396","url":null,"abstract":"<div><div>The rational design of bio-interfaces that efficiently generate reactive oxygen species (ROS) is crucial for antimicrobial therapies. Here, we present a Z-scheme heterojunction of Bi<sub>2</sub>S<sub>3</sub>-Sv/WS<sub>2</sub>, engineered at the interface through in-situ growth to form covalent Bi-S-W bonds. This specific bonding, coupled with introduced sulfur vacancies, creates an asymmetric electron distribution and a built-in electric field. The synergistic effect establishes a direct and rapid pathway for charge carrier transport, which is conclusively verified by femtosecond transient absorption spectroscopy (fs-TAS) to suppress charge recombination and extend carrier lifetimes. Consequently, the system exhibits a significant enhancement in the generation of reactive oxygen species (ROS) under 660 nm light irradiation. The optimized heterojunction demonstrates broad-spectrum antibacterial efficacy, achieving a 99.63 % inhibition rate against both <em>Staphylococcus aureus</em> and <em>Escherichia coli</em> within 15-minute treatment. Furthermore, the material exhibits excellent biocompatibility. This study discloses the role of interfacial chemical bonding and defect engineering in tailoring charge dynamics at the bio-interface, thereby providing a promising strategy for the rational design of highly efficient photocatalytic agents for biomedical applications, such as wound healing and infection control.</div></div>","PeriodicalId":279,"journal":{"name":"Colloids and Surfaces B: Biointerfaces","volume":"260 ","pages":"Article 115396"},"PeriodicalIF":5.6,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145831838","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-04-01Epub Date: 2026-01-02DOI: 10.1016/j.colsurfb.2025.115404
Sabina Arias , Natalia Arancibia , Ramón Rial , Juan Ruso , Marcelo J. Kogan , Natalia Hassan
The functionalization of gold nanoparticles (NPs) with polyethylene glycol (PEG) and folic acid improves their stability, biocompatibility, and targeting capacity, essential for biomedical applications. However, conventional characterization methods often overlook the influence of dynamic biological environments. In this study, we investigated the stability of spherical and rod-shaped gold nanoparticles (GNSs and GNRs) under both static and dynamic conditions, utilizing a microfluidic device designed to emulate a biological environment. Nanoparticles were characterized in terms of hydrodynamic size, zeta potential, and surface plasmon resonance in three distinct media: Milli-Q water, phosphate-buffered saline (PBS), and RPMI 1640 cell culture medium supplemented with 10 % fetal bovine serum. Our findings reveal that protein-rich media enhance nanoparticle stability through the formation of a protein corona, whereas PBS promotes aggregation, particularly under static conditions. Notably, GNRs exhibited higher protein adsorption and superior colloidal stability under flow conditions compared to GNSs, a behavior attributed to their anisotropic geometry and increased surface interaction dynamics. This study underscores the relevance of testing nanoparticle behavior under physiologically relevant flow conditions, providing valuable information to optimize nanoparticle design for nanomedicine.
{"title":"Evaluation of functionalized gold nanoparticles stability in a microfluidic device to mimic a biological environment","authors":"Sabina Arias , Natalia Arancibia , Ramón Rial , Juan Ruso , Marcelo J. Kogan , Natalia Hassan","doi":"10.1016/j.colsurfb.2025.115404","DOIUrl":"10.1016/j.colsurfb.2025.115404","url":null,"abstract":"<div><div>The functionalization of gold nanoparticles (NPs) with polyethylene glycol (PEG) and folic acid improves their stability, biocompatibility, and targeting capacity, essential for biomedical applications. However, conventional characterization methods often overlook the influence of dynamic biological environments. In this study, we investigated the stability of spherical and rod-shaped gold nanoparticles (GNSs and GNRs) under both static and dynamic conditions, utilizing a microfluidic device designed to emulate a biological environment. Nanoparticles were characterized in terms of hydrodynamic size, zeta potential, and surface plasmon resonance in three distinct media: Milli-Q water, phosphate-buffered saline (PBS), and RPMI 1640 cell culture medium supplemented with 10 % fetal bovine serum. Our findings reveal that protein-rich media enhance nanoparticle stability through the formation of a protein corona, whereas PBS promotes aggregation, particularly under static conditions. Notably, GNRs exhibited higher protein adsorption and superior colloidal stability under flow conditions compared to GNSs, a behavior attributed to their anisotropic geometry and increased surface interaction dynamics. This study underscores the relevance of testing nanoparticle behavior under physiologically relevant flow conditions, providing valuable information to optimize nanoparticle design for nanomedicine.</div></div>","PeriodicalId":279,"journal":{"name":"Colloids and Surfaces B: Biointerfaces","volume":"260 ","pages":"Article 115404"},"PeriodicalIF":5.6,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145909570","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
The favourable outcome of gene therapy depends on the developing efficient and safe gene delivery systems. Recently, nonviral vectors have gained considerable attention due to their improved safety profiles and their potential application in viral vector manufacturing. In this study, we report the design, synthesis, and evaluation of novel short-chain (C6) ionizable lipids with varying hydrophobic amino acid headgroups phenylalanine (C6F-IL), tryptophan (C6W-IL), and glycine (C6G-IL) along with a cationic lipid containing twin C12 alkyl chains (C12-CL). Liposomes composed solely of either C6 ionizable amino lipids (C6-IL) or C12-CL were unable to efficiently deliver plasmid DNA. However, an optimized combination of C12-CL and C6 ionizable lipids, particularly C6W-IL (Lipo-3), demonstrated superior transfection efficiency across HEK-293T, SKHEP, and HEPA cell lines, comparable to that of Lipofectamine 3000. Furthermore, when Lipo-3 was applied in lentivirus production, it yielded viral titres equivalent to those obtained using commercial Lipofectamine 3000. These findings demonstrate that a combination of two individually transfection-incompetent lipids can be engineered into a highly efficient liposomal system for gene delivery. This approach provides new opportunities for harnessing existing transfection-incompetent lipids in gene therapy applications.
{"title":"Combination of transfection incompetent lipids having strikingly different aliphatic chain lengths in a liposome demonstrates superior transfection and produces high titre lentivirus","authors":"Yasodha Ramasamy , Ramya Arumugam , Sevanthy Suresh , Gokulnath Mahalingam , Rajesh Kumar Subhaschandra bose , Mohanraj Ramasamy , Ilavarasan Raju , Srujan Marepally","doi":"10.1016/j.colsurfb.2025.115402","DOIUrl":"10.1016/j.colsurfb.2025.115402","url":null,"abstract":"<div><div>The favourable outcome of gene therapy depends on the developing efficient and safe gene delivery systems. Recently, nonviral vectors have gained considerable attention due to their improved safety profiles and their potential application in viral vector manufacturing. In this study, we report the design, synthesis, and evaluation of novel short-chain (C6) ionizable lipids with varying hydrophobic amino acid headgroups phenylalanine (C6F-IL), tryptophan (C6W-IL), and glycine (C6G-IL) along with a cationic lipid containing twin C12 alkyl chains (C12-CL). Liposomes composed solely of either C6 ionizable amino lipids (C6-IL) or C12-CL were unable to efficiently deliver plasmid DNA. However, an optimized combination of C12-CL and C6 ionizable lipids, particularly C6W-IL (Lipo-3), demonstrated superior transfection efficiency across HEK-293T, SKHEP, and HEPA cell lines, comparable to that of Lipofectamine 3000. Furthermore, when Lipo-3 was applied in lentivirus production, it yielded viral titres equivalent to those obtained using commercial Lipofectamine 3000. These findings demonstrate that a combination of two individually transfection-incompetent lipids can be engineered into a highly efficient liposomal system for gene delivery. This approach provides new opportunities for harnessing existing transfection-incompetent lipids in gene therapy applications.</div></div>","PeriodicalId":279,"journal":{"name":"Colloids and Surfaces B: Biointerfaces","volume":"260 ","pages":"Article 115402"},"PeriodicalIF":5.6,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145909555","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}